overactive%20bladder
OVERACTIVE BLADDER

Overactive bladder or non-neurogenic overactive bladder is a syndrome characterized by urinary urgency, frequency, nocturia and urgency incontinence.
It is not a disease but a symptom complex that generally is not a life-threatening condition. It is also known as bladder spasms.
Urgency is the complaint of sudden, compelling desire to pass urine that is difficult to deny. It is considered a hallmark symptom of overactive bladder.
Frequency is usually micturition of >7 episodes during waking hours.
Nocturia is the interruption of sleep one or more times because of the need to void.
Urgency incontinence is the involuntary leakage of urine associated with a sudden compelling desire to void.

Introduction

  • Overactive bladder (OAB) is also known as bladder spasms

Definition

  • Defined by the International Continence Society (ICS) as consisting of the following symptoms: urinary urgency, with or without urgency urinary incontinence, usually with frequency and nocturia, in the absence of causative infection or pathologic conditions, and suggestive of underlying detrusor overactivity (phasic increases in detrusor pressure)

Signs and Symptoms

  • Urinary urgency
    • Complaint of sudden, compelling desire to pass urine which is difficult to defer
    • Considered as the hallmark of overactive bladder (OAB)
    • Number of voids and number of incontinence episodes are used to measure treatment responses
  • Urinary frequency
    • Measured using a voiding diary
    • Number of voiding would vary based on hours of sleep, fluid intake, comorbid medical conditions and other relevant factors
  • Nocturia
    • Complaint of interruption of sleep due to the need to void
  • Urgency urinary incontinence
    • Involuntary leakage of urine, associated with sudden compelling desire to void
    • Measured using a diary and by the quantity of urine leakage using pad tests

Risk Factors

  • ≥40 years old
  • Obesity
  • Previous pelvic and prostate surgery
  • Neurological conditions such as diabetic neuropathy, stroke, spinal cord injury, dementia, Parkinson’s disease and multiple sclerosis

Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
Roshini Claire Anthony, Yesterday

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Stephen Padilla, 4 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.